Jon T. Giles, MD

Expertise in: 
Rheumatoid Arthritis, Spondylitis & Psoriatic Arthritis, Gout
Board Certifications: 
Rheumatology, Internal Medicine
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Spondylitis & Psoriatic Arthritis, Rheumatoid Arthritis, Gout, Inflammatory Arthritis, Pseudo-Gout, Gout, Psoriatic Arthritis, Ankylosing Polyarthritis

Academic Appointments

  • Associate Professor of Medicine

Jon T. Giles, MD - ColumbiaDoctors Rheumatologist

Dr. Giles’ area of clinical interest is in inflammatory arthritis such as rheumatoid arthritis, psoriatic and arthritis, and spondylitis.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-4308

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • Vanderbilt University School of Medicine
  • Internship: University of California San Diego
  • Residency: University of California San Diego
  • Fellowship: Johns Hopkins Hopital

Board Certifications

  • Rheumatology
  • Internal Medicine

Research

Dr. Giles is an epidemiologist and clinical researcher in the Division of Rheumatology at Columbia University. Over the past decade, his research group has focused on understanding the determinants and impacts of extra-articular comorbidities of rheumatoid arthritis.  They have explored the relationships of immune and inflammatory biomarkers with disease activity, articular damage, body composition, disability, cardiovascular disease, and pulmonary disease in individuals with rheumatoid arthritis.  A particular area of focus in the design of these studies has been the appropriate use of analytical modeling, diligent identification, measurement, and control of confounders, and the use of efficient and robust modeling techniques.  The results of these studies have informed the design of translational studies to help define mechanisms. Other current and past research involve the investigation of accelerated atherosclerosis and myocardial dysfunction in rheumatoid arthritis patients, understanding the risks of biologic therapeutic use for patients undergoing surgery, and exploring the musculoskeletal side-effects of a class of medications used to suppress estrogen in women with certain forms of breast cancer. He is the recipient of major grant support from the National Institutes of Health, the Arthritis Foundation, the American College of Rheumatology.

Grants

INFLAMMATION AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS (Federal Gov)

Jun 1 2017 - May 31 2022

ADIPOSE INFLAMMATION IN RHEUMATOID ARTHRITIS (Federal Gov)

Sep 15 2016 - Aug 31 2021

SIGNIFICANCE OF INTRARENAL T CELLS IN SLE NEPHRITIS (Federal Gov)

Jan 25 2016 - Dec 31 2019

CIRCULATING ADIPOKINE LEVELS AS PREDICTORS OF MRI AND PLAIN RADIOGRAPHIC EROSIONS IN EARLY RHEUMATOID ARTHRITIS (Private)

Jan 13 2017 - Jan 31 2019

ADIPOSE INFLAMMATION AND HLA OBESITY INTERACTIONS IN PSORIATIC ARTHRITIS (Private)

Jul 1 2015 - Jun 30 2017

PREDICTORS OF PROGRESSION OF ATHEROSCLEROSIS IN RA (Private)

Jul 1 2015 - Jun 30 2017

OBESITY, INFLAMMATION AND LUNG INJURY AFTER LUNG TRANSPLANTATION (Federal Gov)

May 23 2013 - Mar 31 2017

TREATMENTS AGAINST RA AND EFFECT ON FDG PET/CT: THE TARGET TRIAL (Federal Gov)

Sep 28 2015 - Jun 30 2016

CIRCULATING ADIPOKINE LEVELS AS PREDICTORS OF RADIOGRAPHIC PROGRESSION AMONG EARLY RHEUMATOID ARTHRITIS PATIENTS ENROLLED IN THE TEAR TRIAL (Private)

Jul 1 2014 - Jun 30 2016

PSYCHOSOCIAL COMORBIDITIES AND SUBCLINICAL ATHERSCLEROSIS AND QUALITY OF LIFE IN RHEUMATOID ARTHRITIS: COMPARISON WITH THE MULTI-ETHNIC STUDY OF ARTHEROSCLEROSIS (Private)

Dec 2 2014 - Dec 2 2015

EVALUATION OF AN EDUCATION AND ELECTRONIC MEDICAL RECORD BASED VACCINATION OPTIMIZATION INTERVENTION IN RHEUMATOID ARTHRITIS (Private)

Jul 1 2013 - Jun 30 2015

PATHWAYS AND BIOMARKERS OF MYOCARDIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS (Private)

Jul 1 2013 - Jun 30 2015

TREAT TO TARGET TO REDUCE ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS (Federal Gov)

Apr 1 2013 - Mar 31 2015

ADIPOSE TISSUE INFLAMMATION IN RHEUMATOID ARTHRITIS: ASSOCIATIONS WITH DISEASE CHARACTERISTICS, CARDIOMETABOLIC RISK FACTORS, AND ATHEROSCLEROSIS (Private)

Jul 1 2012 - Jun 30 2014

DETERMINANTS OF BODY COMPOSITION IN RHEUMATOID ARTHRITIS (Federal Gov)

Sep 1 2006 - Aug 31 2012

MECHANISMS OF MYOCARDIAL DYSFUNCTION IN RHEUMATOID ARTHRITIS (Private)

Dec 1 2010 - Jun 30 2012